Skip to Main Content

Print | Bookmark | Email | Font Size: + |

October 1, 2019

Ohio Open Public LCD Discussion Meeting: Draft Local Coverage Determinations — Wednesday, October 30th, 2019

CGS will host an Open Meeting for comments from physicians/providers and the general public related to the development of Local Coverage Determinations (LCDs) for Medicare Jurisdiction 15 on October 30th, 2019 at the following time and location:


Wednesday, October 30th, 2019


4:00-5:00 p.m. ET


OSU Physicians, Inc.
700 Ackerman Rd., Suite 6000A
Columbus, Ohio 43202

Please note that this is the Open Public meeting to discuss the development process of Draft LCDs or Revisions to current LCDs and not the Contractor Advisory Committee Meetings (CAC).

The following teleconference/webinar information is available for those of you who are unable to attend in person. Please note that you must register in order to attend via webinar:

Registration InformationExternal Website

Draft Policies

The following policies were written for provider guidance and/or updated based on new technology and information available:

DL38288-MolDX: Repeat Germline Testing

DL38303-MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Favorable Intermediate Risk Disease

DL38305-MolDX: Signatera and Minimal Residual Disease Testing for Colorectal Cancer

DL38307-Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea

DL38247-MolDX: SelectMDx for Prostate Cancer

DL38249-MolDX: Erythrocyte Molecular Antigen Typing

DL37836-MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC)

DL38268-Immune Thrombocytopenia (ITP) Therapy

DL38016-MolDX: DecisionDx-Melanoma

DL38272-MolDX: AlloSure® Cell-Free DNA Testing

DL38270-MolDX: Molecular Microscope® Diagnostic System for the Heart

DL38282-Tests on Allograft Kidney Biopsy Tissue to Assess for Graft Rejection

DL38284-MolDX: Razor 14-Gene Lung Cancer Assay

DL38378-Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)

DL38394- MolDX: Psychiatric Pharmacogenomics Testing

Draft LCD Link: Ohio Proposed/Draft LCDs Not Released to FinalExternal Website

Interested parties who wish to make presentations related to the draft LCD(s) must submit a written request, no later than October 16th, 2019 to and include the following information:

  • Name, address, telephone number and e-mail address of presenter
  • Name, address, telephone number and e-mail address of organization
  • Name of draft LCD
  • Copy of the presentation(s)
  • Completed Conflict of Interest (COI) FormMicrosoft Word File for each topic you wish to present

The presentation and COI form must be attached to your request(s). Each presenter will have equal time based on the number of presentations requested. Once all requests are received we will notify each presenter of the time allocation via email by 10/23/2019.

Future Meetings:



26 Century Blvd Ste ST610, Nashville, TN 37214-3685 © CGS Administrators, LLC. All Rights Reserved